• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环代谢组学揭示鸟苷单磷酸合成酶(GMPS)是肺腺癌的一个新治疗靶点。

Circulating metabolomics reveals guanosine monophosphate synthetase (GMPS) as a novel therapeutic target in lung adenocarcinoma.

作者信息

Yu Mengjie, Yang Dou, Zhu Danxia, Wang Yue, Cao Minmin, Zhu Jingfeng, Zhu Wei, Wang Guangji, Aa Jiye

机构信息

State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, PR China.

Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, PR China.

出版信息

J Pathol. 2025 Aug;266(4-5):465-480. doi: 10.1002/path.6442. Epub 2025 Jun 20.

DOI:10.1002/path.6442
PMID:40539844
Abstract

Metabolic reprogramming is pivotal in the initiation and progression of lung adenocarcinoma (LUAD). However, a substantial gap remains in the understanding of the primary drivers of metabolic reprogramming and alterations in early-stage LUAD. Using an unbiased, large-scale metabolomics analysis of 2,531 plasma and serum samples from three independent clinical centers, we identified significant perturbations in purine metabolism that characterized reprogrammed metabolism in early-stage LUAD. Additionally, hypoxanthine (p < 0.001) and xanthine (p < 0.05) were identified as two typical early risk indicators, with odd ratios (ORs) more than 2.8 and 1.45, respectively. Guanosine monophosphate synthetase (GMPS) was identified as a pivotal factor in the early development and malignant progression of LUAD. Progression of LUAD was significantly attenuated by GMPS knockdown and markedly exacerbated by its overexpression. Further data indicated that GMPS primarily contributed to the reprogrammed metabolic phenotypes of LUAD through its enzymatic activity and subsequent production of purine nucleotides, based on the relative abundance of the labeled isotope metabolites. Collectively, dysregulated purine metabolism emerged as a key characteristic of early-stage LUAD, and targeting GMPS activity may offer a promising therapeutic potential for LUAD treatment. © 2025 The Pathological Society of Great Britain and Ireland.

摘要

代谢重编程在肺腺癌(LUAD)的发生和发展中起着关键作用。然而,在对代谢重编程的主要驱动因素以及早期LUAD中的变化的理解方面仍存在很大差距。通过对来自三个独立临床中心的2531份血浆和血清样本进行无偏倚的大规模代谢组学分析,我们确定了嘌呤代谢的显著扰动,这是早期LUAD中重编程代谢的特征。此外,次黄嘌呤(p<0.001)和黄嘌呤(p<0.05)被确定为两个典型的早期风险指标,其优势比(OR)分别超过2.8和1.45。鸟苷单磷酸合成酶(GMPS)被确定为LUAD早期发展和恶性进展的关键因素。GMPS基因敲低显著减弱了LUAD的进展,而其过表达则明显加剧了LUAD的进展。进一步的数据表明,基于标记同位素代谢物的相对丰度,GMPS主要通过其酶活性和随后嘌呤核苷酸的产生,促成了LUAD的重编程代谢表型。总的来说,嘌呤代谢失调成为早期LUAD的一个关键特征,靶向GMPS活性可能为LUAD治疗提供有前景的治疗潜力。©2025年英国和爱尔兰病理学会。

相似文献

1
Circulating metabolomics reveals guanosine monophosphate synthetase (GMPS) as a novel therapeutic target in lung adenocarcinoma.循环代谢组学揭示鸟苷单磷酸合成酶(GMPS)是肺腺癌的一个新治疗靶点。
J Pathol. 2025 Aug;266(4-5):465-480. doi: 10.1002/path.6442. Epub 2025 Jun 20.
2
Unraveling the role of GPCR signaling in metabolic reprogramming and immune microenvironment of lung adenocarcinoma: a multi-omics study with experimental validation.揭示GPCR信号在肺腺癌代谢重编程和免疫微环境中的作用:一项具有实验验证的多组学研究
Front Immunol. 2025 Jun 6;16:1606125. doi: 10.3389/fimmu.2025.1606125. eCollection 2025.
3
Multisite DNA methylation alterations of peripheral blood mononuclear cells serve as novel biomarkers for the diagnosis of AIS/stage I lung adenocarcinoma: a multicenter cohort study.外周血单个核细胞的多部位DNA甲基化改变作为早期侵袭性肺腺癌/Ⅰ期肺腺癌诊断的新型生物标志物:一项多中心队列研究
Int J Surg. 2025 Jan 1;111(1):40-54. doi: 10.1097/JS9.0000000000002101.
4
Liquid-Liquid Phase Separation in the Prognosis of Lung Adenocarcinoma: An Integrated Analysis.液-液相分离在肺腺癌预后中的综合分析
Curr Cancer Drug Targets. 2025;25(4):323-334. doi: 10.2174/0115680096345676241001081051.
5
A novel disulfidptosis-related prognostic gene signature and experimental validation identify as a novel therapeutic target in lung adenocarcinoma.一种新型的与铁死亡相关的预后基因特征及实验验证确定其为肺腺癌中的一个新型治疗靶点。
Cancer Biomark. 2025 Jan;42(1):CBM230276. doi: 10.3233/CBM-230276. Epub 2024 Feb 12.
6
Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation.小窝蛋白-1通过表皮生长因子受体(EGFR)降解抑制肺腺癌的增殖和侵袭。
Sci Rep. 2025 Jul 1;15(1):21654. doi: 10.1038/s41598-025-05259-8.
7
Comprehensive analysis of RFC4 as a potential biomarker for regulating the immune microenvironment and predicting immune therapy response in lung adenocarcinoma.对RFC4作为调节肺腺癌免疫微环境和预测免疫治疗反应的潜在生物标志物的综合分析。
Front Immunol. 2025 Jun 19;16:1578243. doi: 10.3389/fimmu.2025.1578243. eCollection 2025.
8
Prognostic model of lung adenocarcinoma based on disulfidptosis-related genes and analysis of in vitro cell experiments for PPP1R14B in the model.基于二硫键化相关基因的肺腺癌预后模型及模型中PPP1R14B的体外细胞实验分析
Biol Direct. 2025 Jul 1;20(1):74. doi: 10.1186/s13062-025-00662-7.
9
GPM6B inhibits tumor progression by targeting HPGD in lung adenocarcinoma.GPM6B通过靶向肺腺癌中的HPGD抑制肿瘤进展。
Mol Med Rep. 2025 Sep;32(3). doi: 10.3892/mmr.2025.13618. Epub 2025 Jul 11.
10
Integrative metagenomic, transcriptomic, and proteomic analysis reveal the microbiota-host interplay in early-stage lung adenocarcinoma among non-smokers.综合宏基因组学、转录组学和蛋白质组学分析揭示了非吸烟人群早期肺腺癌中微生物组-宿主相互作用。
J Transl Med. 2024 Jul 13;22(1):652. doi: 10.1186/s12967-024-05485-0.